Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1

Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1

Background Heart pathological hypertrophy has been recognized as a predisposing risk factor for heart failure and arrhythmia. DUSP (dual‐specificity phosphatase) 26 is a member of the DUSP family of proteins, which has a significant effect on nonalcoholic fatty liver disease, neuroblastoma, glioma,...

Full description

Bibliographic Details
Main Authors: Jing Zhao, Xiaoli Jiang, Jinhua Liu, Ping Ye, Lang Jiang, Manhua Chen, Jiahong Xia
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiac hypertrophy
DUSP26
heart failure
TAK1
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014311

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.014311

Similar Items